Phototherapy and malignancy: Possible enhancement by iron administration and hyperbaric oxygen

Medical Hypotheses

Volumn 67, Issue 5, 2006, Pages 1148-1158

  AL Waili, Noori S ^a   Butler, Glenn J ^a  

^a NEWTechnologies Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOLEVULINIC ACID; FERRIC HYDROXIDE SUCROSE; FERROUS GLUCONATE; HEMATOPORPHYRIN DERIVATIVE; HEMIN; HYDROGEN PEROXIDE; IRON; IRON DEXTRAN; OXYGEN RADICAL; PHOTOFRIN; PORPHYRIN;

ACNE; ACTINIC KERATOSIS; ANAPHYLAXIS; ARTICLE; BLEEDING; BLISTER; BURN; CANCER CELL; CELL DAMAGE; CELL KILLING; DRUG HALF LIFE; DRUG SAFETY; ENTERITIS; GASTROINTESTINAL SYMPTOM; HEPATIC PORPHYRIA; HUMAN; HYPERBARIC OXYGEN; HYPEROXIA; HYPOXIA; INJECTION SITE INFLAMMATION; INJECTION SITE PAIN; INTESTINE ABSORPTION; IRON OVERLOAD; IRON THERAPY; LEUKEMIA CELL; MALIGNANT NEOPLASTIC DISEASE; MULTIMODALITY CANCER THERAPY; PARESTHESIA; PHOTOSENSITIZATION; PHOTOTHERAPY; PRIORITY JOURNAL; PRURITUS; PSORIASIS; SKIN CANCER; SKIN DISCOLORATION; TISSUE INJURY; TUMOR CELL;

AMINOLEVULINIC ACID; COMBINED MODALITY THERAPY; HEME; HEME OXYGENASE-1; HUMANS; HYPERBARIC OXYGENATION; IRON; MITOCHONDRIA; NEOPLASMS; OXIDATION-REDUCTION; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; REACTIVE OXYGEN SPECIES;

EID: 33748153208     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2005.12.052     Document Type: Article

References (97)

1. Toyokuni S. Iron-induced carcinogenesis: the role of redox regulation. Free Radical Biol Med 20 (1996) 553-566
2. Schaible U.E., and Kaufmann S.H. Iron and microbial infection. Nat Rev Microbiol 3 3 (2005) 268
3. Bowlus C. The role of iron in T cell development and autoimmunity. Autoimmun Rev 2 (2003) 73-78
4. Jiang X., and Baldwin C.L. Iron augments macrophage-mediated killing of Brucella abortus alone and in conjunction with interferon. Cell Immunol 148 (1993) 397-407
5. Saleppico S., Mazzolla R., Boelaert J.R., Puliti M., Barluzzi R., Bistoni F., et al. Iron regulates microglial cell-mediated secretory and effector functions. Cell Immunol 170 (1996) 251-259
6. Ghio A.J., Piantadosi C.A., and Crumbliss A.L. Hypothesis: iron chelation plays a vital role in neutrophilic inflammation. Biometals 19 (1997) 135-142
7. Hoepelman I.M., Bezemer W.A., Vandenbroucke-Grauls C.M.J.E., Marx J.J.M., and Verhoef J. Bacterial iron enhances oxygen radical-mediated killing of Staphylococcus aureus by phagocytes. Infect Immun 58 (1990) 26-31
8. Weinberg D. Roles of iron in neoplasia. Promotion, prevention, and therapy. Biol Trace Elem Res 34 (1992) 123-140
9. Boldt H. New perspectives on iron: an introduction. Am J Med Sci 318 (1999) 207-212
10. Kwok J., and Richardson D. The iron metabolism of neoplastic cells: alterations that facilitate proliferation?. Crit Rev Oncol Hematol 42 (2002) 65-78
11. Lin F., Bertling C.J., Geiger P., and Girotti A. Delayed hyperresistance of endothelial cells to photodynamic inactivation after contact with hemin. Photochem Photobiol 68 (1998) 211-217
12. Erario M., Gonzales S., Noriega G., and Tomaro M.L. Bilirubin and ferritin as protectors against hemin-induced oxidative stress in rat liver. Cell Mol Biol (Noisy-le-grand) 48 (2002) 877-884
13. Niinikoski J.H. Clinical hyperbaric oxygen therapy, wound perfusion, and transcutaneous oximetry. World J Surg 28 (2004) 307-311
14. Veltkamp R., Siebing D.A., Sun L., Heiland S., Bieber K., Marti H.H., et al. Hyperbaric oxygen reduces blood-brain barrier damage and edema after transient focal cerebral ischemia. Stroke 36 (2005) 1679-1683
15. AL-Waili N., Butler G., Beale J., Hamilton R., Lee B., and Lucas P. Hyperbaric oxygen and malignancies: a potential role in radiotherapy, chemotherapy, tumor surgery and phototherapy. Med Sci Monit 9 (2005) RA279-89
16. Al-Waili N., Butler G., Beale J., Abdullah M., Hamilton R., Lee B., et al. Hyperbaric oxygen for cerebral stroke, brain trauma and neurological diseases: a promising future application. Adv Ther 22 (2005) 659-678
17. Abdulla M., AL-Waili N., Butler G., and Banna J. Hyperbaric oxygen as an adjunctive therapy for bilateral compartment syndrome, rhabdomyolysis and acute renal failure after heroin intake. Arch Med Res 37 (2006) 559-562
18. Peng Q., Berg K., Moan J., Kongshaug M., and Nesland J. 5-Aminolevulinic acid-based photodynamic therapy: principles and experimental research. Photochem Photobiol 65 (1997) 235-251
19. De Rosa F., and Bentley V. Photodynamic therapy of skin cancers: sensitizers, clinical studies and future directives. Pharm Res 17 (2000) 1447-1455
20. Kennedy J.C., Marcus S.L., and Pottier R.H. Photodynamic therapy (PDT) and photodiagnosis (PD) using endogenous photosensitization induced by 5-aminolevulinic acid (ALA): mechanisms and clinical results. J Clin Laser Med Surg 14 5 (1996) 289-304
21. Dougherty T., Gomer C., Henderson B., Jori G., Kessel D., Korbelik M., et al. Photodynamic therapy. J Natl Cancer Inst 90 (1998) 889-905
22. Dalla Via L., and Marciani Magno S. Photochemotherapy in the treatment of cancer. Curr Med Chem 8 (2001) 1405-1418
23. Sibata C., Colussi C.V., Oleinick L., and Kinsella T. Photodynamic therapy in oncology. Expert Opin Pharmacother 2 (2001) 917-927
24. Har-El R., Marva E., Chevion M., and Golenser J. Is hemin responsible for the susceptibility of plasmodia to oxidant stress?. Free Radical Res Commun 18 (1993) 279-290
25. Levere R.D., Martasek P., Escalante B., Schwartzman M.L., and Abraham N.G. Effect of heme arginate administration on blood pressure in spontaneously hypertensive rats. J Clin Invest 86 (1990) 213-219
26. Martasek P., Schwartzman M.L., Goodman A.I., Solangi K.B., Levere R., and Abraham N.G. Hemin and l-arginine regulation of blood pressure in spontaneously hypertensive rats. J Am Soc Nephrol 2 (1991) 1078-1084
27. Ndisang J., Wu L., Zhao W., and Wang R. Induction of heme oxygenase-1 and stimulation of cGMP production by hemin in aortic tissues from hypertensive rats. Blood 101 (2003) 3893-3900
28. Furchgott R.F., and Jothianandan D. Endothelium-dependent and -independent vasodilation involving cyclic GMP: relaxation induced by nitric oxide, carbon monoxide and light. Blood Vessels 28 (1991) 52-61
29. Muller C.I., Miller C.W., Kawabata H., McKenna Jr. R.J., Marchevsky A.M., and Koeffler H.P. Do cancer cells selectively mutate HFE to increase their intracellular iron?. Oncol Rep 14 (2005) 299-303
30. Wiemann T.J., Mang T.S., and Fingar V.H. Effect of photodynamic therapy on blood flow in normal and tumour vessels. Surgery 194 (1988) 512-517
31. Dong G.C., Hu S.X., Zhao G.Y., Gao S.Z., and Wu L.R. Experimental study on cytotoxic effects of hyperbaric oxygen and photodynamic therapy on mouse transplanted tumours. Chin Med J Engl 100 (1987) 697-702
32. Jirsa Jr. M., Pouckiva P., Dolezal J., Pospisil J., and Jirsa M. Hyperbaric oxygen and photodynamic therapy in tumour bearing nude mice. Eur J Cancer 27 (1991) 109-110
33. van den Boogert J., van Staveren H.J., de Bruin R.W., Eikelaar J.H., Siersema P.D., and van Hillegersberg R. Photodynamic therapy for esophageal lesions: selectivity depends on wavelength, power, and light dose. Ann Thorac Surg 68 (1999) 1763-1769
34. Fink-Puches R., Soyer H.P., Hofer A., Kerl H., and Wolf P. Long-term follow-up and histological changes of superficial nonmelanoma skin cancers treated with topical δ-aminolevulinic acid photodynamic therapy. Arch Dermatol 134 (1998) 821-826
35. Henderson B., and Fingar V. Relationship of tumor hypoxia and response to photodynamic treatment in an experimental mouse tumor. Cancer Res 47 (1987) 3110-3114
36. Herzog M., Moser J., Wagner B., and Broecker J. Shielding effects and hypoxia in photodynamic therapy. Int J Oral Maxillofac Surg 23 (1994) 406-408
37. Fuchs J, Thiele J. The role of oxygen in cutaneous photodynamic therapy. Free Radical Biol Med 24:835-47. Effects of fluence rate. Br J Cancer 77 (1998) 1386-1394
38. Maier A., Anegg U., Tomaselli F., Rehak P., Sankin O., Fell B., et al. Does hyperbaric oxygen enhance the effect of photodynamic therapy in patients with advanced esophageal carcinoma? A clinical pilot study. Endoscopy 32 (2000) 42-48
39. Maier A., Anegg U., Fell B., Rehak P., Ratzenhofer B., Tomaselli F., et al. Hyperbaric oxygen and photodynamic therapy in the treatment of advanced carcinoma of the cardia and the esophagus. Lasers Surg Med 26 (2000) 308-315
40. Maier A., Anegg U., Fell B., Tomaselli F., Sankin O., Prettenhofer U., et al. Effect of photodynamic therapy in a multimodal approach for advanced carcinoma of the gastro-esophageal junction. Lasers Surg Med 26 (2000) 461-466
41. Tomaselli F., Maier A., Sankin O., Anegg U., Stranzl H., Pinter K., et al. Acute effects of combined photodynamic therapy and hyperbaric oxygenation in lung cancer-a clinical pilot study. Lasers Surg Med 28 (2000) 399-403
42. Tomaselli F., Maier A., Pinter H., Stranzl H., and Smolle-Juttner F. Photodynamic therapy enhanced by hyperbaric oxygen in acute endoluminal palliation of malignant bronchial stenosis (clinical pilot study in 40 patients). Eur J Cardiothorac Surg 5 (2001) 549-554
43. Al-Waili N. Oxidant stress: a common cause for diseases. Al-Siha Al-Teb 188 (2002) 19-25
44. Pu H., Sakaguchi M., Kondo T., Kondo A., Kawabata T., and Namba M. Effects of oxygen concentrations on human fibroblasts treated with Fe(3+)-NTA. Int J Mol Med 7 (2001) 295-300
45. Toyokuni S., and Sagripanti L. Iron-mediated DNA damage: sensitive detection of DNA strand breakage catalyzed by iron. J Inorg Biochem 47 (1992) 241-248
46. Chen Y., Lu J., Gau J., Yang L., and Huang S. 15-Deoxy-δ12,14-prostaglandin J2 induces apoptosis of a thyroid papillary cancer cell line (CG3 cells) through increasing intracellular iron and oxidative stress. Anticancer Drugs 13 (2002) 759-765
47. Weinberg E.D. Iron in neoplastic disease. Nutr Cancer 4 (1983) 223-233
48. Weinberg E.D. The role of iron in cancer. Eur J Cancer Prev 5 (1996) 19-36
49. Elliott R., Head J., and McCoy J. Relationship of serum and tumor levels of iron and iron-binding proteins to lymphocyte immunity against tumor antigen in breast cancer patients. Breast Cancer Res Treat 30 (1994) 305-309
50. Picurelli L., Olcina P.V., Roig M.D., Molina E., and Ferrer J. Determination of serum Fe in prostatic pathology. Actas Urol Esp 14 (1990) 262-263
51. Al-Waili N., and Al-Azzawi H. The effects of prostaglandin E2 on serum Iron following acute and chronic blood loss. Clin Exp Pharm Physiol 12 (1985) 443-445
52. Stevens G., and Kalkwarf R. Iron, radiation, and cancer. Environ Health Perspect 87 (1990) 291-300
53. Nunez M., Tapia V., Toyokuni S., and Okada S. Iron-induced oxidative damage in colon carcinoma (Caco-2) cells. Free Radical Res 34 (2001) 57-68
54. Elliott R., Elliott M., Wang F., and Head J. Breast carcinoma and the role of iron metabolism. A cytochemical, tissue culture, and ultrastructural study. Ann N Y Acad Sci 698 (1993) 159-166
55. Thorstensen K., and Romslo I. The transferrin receptor: its diagnostic value and its potential as therapeutic target. Scand J Clin Lab Invest Suppl 215 (1993) 113-120
56. Ahlawat S., Bhargava M., Arya L.S., Kochupillai V., and Kumar R. Role of serum ferritin in assessment of disease activity in acute and chronic leukemia. Indian J Med Res 100 (1994) 66-69
57. Bolarin D. Serum ferritin in Nigerian patients with Burkitt's lymphoma and other malignant diseases. Acta Trop 40 (1983) 71-77
58. Gierek T., Kokot F., Pilch J., Wiecek A., Paluch J., and Franek E. The concentration of ferritin in blood serum of patients with neoplasms of the larynx and the maxillary-ethmoidal complex. Otolaryngol Pol 49 Suppl. 20 (1995) 81-83
59. Ladenstein R., Ambros P.F., Urban C., Ambros I.M., Fink F.M., Zoubek A., et al. Value of prognostic factors in the Austrian A-NB87 neuroblastoma study. Klin Padiatr 208 (1996) 210-220
60. Milman N., and Pedersen L.M. The serum ferritin concentration is a significant prognostic indicator of survival in primary lung cancer. Oncol Rep 9 (2002) 193-198
61. Pinto V., Marinaccio M., Garofalo S., Vittoria Larocca A.M., Geusa S., Lanzilotti G., et al. Preoperative evaluation of ferritinemia in primary epithelial ovarian cancer. Tumori 83 (1997) 927-929
62. Takai K., Kojima H., Kume H., Yoshimura M., Kitagawa M., Takemura T., et al. Analysis of ferritin immunostaining in testicular tumors. Hinyokika Kiyo 37 (1991) 363-368
63. Ali M.A., Akhmedkhanov A., Zeleniuch-Jaquotte A., Toniolo P., Frenkel K., and Huang X. Reliability of serum iron, ferritin, nitrite, and association with risk of renal cancer in women. Cancer Detect Prev 27 (2003) 116-121
64. Cermak J., Balla J., Jacob H.S., Balla G., Enright H., Nath K., et al. Tumor cell heme uptake induces ferritin synthesis resulting in altered oxidant sensitivity: possible role in chemotherapy efficacy. Cancer Res 53 (1993) 5308-5313
65. Chen Q., Huang Z., Chen H., Shapiro H., Beckers J., and Hetzel F. Improvement of tumor response by manipulation of tumor oxygenation during photodynamic therapy. Photochem Photobiol 76 (2002) 197-203
66. Dong G.C., Hu S., Zhao G., Gao S., and Wu L. Experimental study on cytotoxic effects of hyperbaric oxygen and photodynamic therapy on mouse transplanted tumor. Chin Med J 100 (1987) 697-702
67. Chen Q., Chen H., Murphy J., Shapiro H., and Hetzel F. Oxygen effect of photodynamic therapy. Proc SIPE 2972 (1997) 80-87
68. Huang Z., Chen Q., Shakil A., Chen H., Beckers J., Shapiro H., et al. Hyperoxygenation enhances the tumor cell killing of photofrin-mediated photodynamic therapy. Photochem Photobiol 78 (2003) 496-502
69. Maier A., Tomaselli F., Anegg U., Rehak P., Fell B., Luznik S., et al. Combined photodynamic therapy and hyperbaric oxygenation in carcinoma of the esophagus and the esophago-gastric junction. Eur J Cardiothorac Surg 18 6 (2000) 649-654
70. Bissonette R., Bergeron A., and Liu Y. Large surface photodynamic therapy with aminolevulinic acid: treatment of actinic keratoses and beyond. J Drugs Dermatol 3 Suppl. 1 (2004) S26-S31
71. Dragieva G., Hafner J., Dummer R., Schmid-Grendelmeier P., Roos M., Prinz B.M., et al. Topical photodynamic therapy in the treatment of actinic keratoses and Bowen's disease in transplant recipients. Transplantation 77 January (2004) 115-121
72. Fehr M.K., Hornung R., Schwarz V.A., Simeon R., Haller U., and Wyss P. Photodynamic therapy of vulvar intraepithelial neoplasia III using topically applied 5-aminolevulinic acid. Gynecol Oncol 80 (2001) 62-66
73. Moan J., Peng Q., Sorensen R., Jani V., and Nesland J.M. Biophysical foundations of photodynamic therapy. Endoscopy 30 (1998) 387-391
74. Karrer S., Szeimies R.M., Hohenleutner U., and Landthaler M. Role of lasers and photodynamic therapy in the treatment of cutaneous malignancy. Am J Clin Dermatol 2 (2001) 229-237
75. Bachor R., Reich E., Ruck A., and Hautmann R. Aminolevulinic acid for photodynamic therapy of bladder carcinoma cells. Urol Res 24 5 (1996) 285-289
76. Kennedy J.C., Pottier R.H., and Pross D.C. Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience. J Photochem Photobiol B 6 (1990) 143-148
77. Kennedy J., and Pottier R.H. Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy. J Photochem Photobiol B 14 (1992) 275-292
78. Hajri A., Wack S., Meyer C., Smith M.K., Leberquier C., Kedinger M., et al. In vitro and in vivo efficacy of photofrin and pheophorbide a, a bacteriochlorin, in photodynamic therapy of colonic cancer cells. Photochem Photobiol 75 (2002) 140-148
79. Leveckis J., Burn J.L., Brown N.J., and Reed M.W.R. Kinetics of endogenous protoporphyrin IX induction by aminolevulinic acid: preliminary studies in the bladder. J Urol 152 (1994) 550-553
80. Malik Z., Ehrenberg B., and Faraggi A. Inactivation of erythrocytic, lymphocytic and myelocytic leukemic cells by photoexcitation of endogenous porphyrins. J Photochem Photobiol B 4 (1989) 195-205
81. Surico G., Muggeo P., Muggeo V., Lucarelli A., Martucci T., Daniele M., et al. Parenteral iron supplementation for the treatment of iron deficiency anemia in children. Ann Hematol 81 (2002) 154-157
82. Bayoumeu F., Subiran-Buisset C., Baka N.E., Legagneur H., Monnier-Barbarino P., and Laxenaire M.C. Iron therapy in iron deficiency anemia in pregnancy: intravenous route versus oral route. Am J Obstet Gynecol 186 (2002) 518-522
83. Maslovsky I. Intravenous iron in a primary-care clinic. Am J Hematol 78 4 (2005) 261-264
84. Silverstein S.B., and Rodgers G.M. Parenteral iron therapy options. Am J Hematol 76 (2004) 74-78
85. Kosch M., and Schaefer R.M. Indications and practical management of parenteral iron therapy. Wien Klin Wochenschr 115 (2003) 380-384
86. Okada S. Iron-induced tissue damage and cancer: the role of reactive oxygen species-free radicals. Pathol Int 46 (1996) 311-332
87. Weinberg D. Cellular regulation of iron assimilation. Q Rev Biol 64 (1989) 261-290
88. Ebina Y., Okada S., Hamazaki S., Ogino F., Li L., and Midorikawa O. Nephrotoxicity and renal cell carcinoma after use of iron- and aluminum-nitrilotriacetate complexes in rats. J Natl Cancer Inst 76 (1986) 107-113
89. Li J., Okada S., Hamazaki S., Ebina Y., and Midorikawa O. Subacute nephrotoxicity and induction of renal cell carcinoma in mice treated with ferric nitrilotriacetate. Cancer Res 47 (1987) 1867-1869
90. Okada S., Hamazaki S., Toyokuni S., and Midorikawa O. Induction of mesothelioma by intraperitoneal injections of ferric saccharate in male Wistar rats. Br J Cancer 60 (1989) 708-711
91. Lee S., Jang C., and Lee S. Tyrosine kinase is involved in hemin-induced pyresis. Arch Pharm Res 26 (2003) 411-415
92. Webber J., Kessel D., and Fromm D. Side effects and photosensitization of human tissues after aminolevulinic acid. J Surg Res 68 (1997) 31-34
93. Ackroyd R., Brown N., Vernon D., Roberts D., Stephenson T., Marcus S., et al. 5-Aminolevulinic acid photosensitization of dysplastic Barrett's esophagus: a pharmacokinetic study. Photochem Photobiol 70 (1999) 656-662
94. Skyrme R.J., French A.J., Datta S.N., Allman R., Mason M.D., and Matthews P.N. A phase-1 study of sequential mitomycin C and 5-aminolaevulinic acid-mediated photodynamic therapy in recurrent superficial bladder carcinoma. BJU Int 95 9 (2005) 1206-1210
95. Herman M.A., Webber J., Fromm D., and Kessel D. Hemodynamic effects of 5-aminolevulinic acid in humans. J Photochem Photobiol B 43 (1998) 61-65
96. Calzavara-Pinton P.G., Szeimies R.M., Ortel B., and Zane C. Photodynamic therapy with systemic administration of photosensitizers in dermatology. J Photochem Photobiol B 36 (1996) 225-231
97. Reizenstein P. Iron, free radicals and cancer. Med Oncol Tumor Pharmacother 8 (1991) 229-233